Invention Grant
- Patent Title: ATR inhibitor and application thereof
-
Application No.: US16968429Application Date: 2019-02-02
-
Publication No.: US11434232B2Publication Date: 2022-09-06
- Inventor: Wenyuan Qian , Jian Wang , Jie Li , Jian Li , Shuhui Chen
- Applicant: WUXI BIOCITY BIOPHARMACEUTICS CO., LTD.
- Applicant Address: CN Jiangsu
- Assignee: WUXI BIOCITY BIOPHARMACEUTICS CO., LTD.
- Current Assignee: WUXI BIOCITY BIOPHARMACEUTICS CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: Ice Miller LLP
- Priority: CN201810124494.2 20180207,CN201811361512.5 20181115
- International Application: PCT/CN2019/074578 WO 20190202
- International Announcement: WO2019/154365 WO 20190815
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D471/04 ; A61P35/00
Abstract:
Disclosed are a compound as an ATR inhibitor and an application in preparing a drug as an ATR inhibitor. In particular, disclosed is a compound represented by formula (I) or an isomer or pharmaceutically acceptable salt thereof.
Information query
